About Strides Pharma Science Ltd
Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India. They are engaged in the development, manufacturing and marketing of pharmaceutical products, with a strong focus on providing high-quality, affordable medicines across global markets. They specialise in niche and technically complex (difficult to manufacture) generic finished dosage formulations.
Founded
1990
CEO
Arun Kumar
Employees
5,394
HQ
Bangalore, India
Finished Products
1Sale of Products
₹5,853.93Cr2Other Operating Income
₹93.76Cr3Export incentives
₹90.49Cr4Support Service Income
₹83.64Cr5Sale of Services
₹23.65Cr6Saleof Intellectual Prop.Right
₹19.47Cr7Royalty received
₹15.64Cr1–7 of 9
Raw Materials
1Raw Materials consumed
₹4,075.75Cr2Finished Goods Purchased
₹131.23Cr3Others-Purchases
₹91.86CrAbout Strides Pharma Science Ltd
Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India. They are engaged in the development, manufacturing and marketing of pharmaceutical products, with a strong focus on providing high-quality, affordable medicines across global markets. They specialise in niche and technically complex (difficult to manufacture) generic finished dosage formulations.
Founded:1990
CEO:Arun Kumar
Employees:5,394
HQ:Bangalore, India
Finished Products
1Sale of Products
₹5,853.93Cr2Other Operating Income
₹93.76Cr3Export incentives
₹90.49Cr4Support Service Income
₹83.64Cr5Sale of Services
₹23.65Cr6Saleof Intellectual Prop.Right
₹19.47Cr7Royalty received
₹15.64Cr1–7 of 9
Raw Materials
1Raw Materials consumed
₹4,075.75Cr2Finished Goods Purchased
₹131.23Cr3Others-Purchases
₹91.86CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,231
52W Low
₹769
Volume327.41K
Avg VolumeN/A
Beta0.60
Dividend Yield0.48%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
15.22x
Valuation
P/B Ratio
3.11x
Valuation
EPS
₹68.83
Valuation
Dividend Yield
0.48%
Valuation
ROE
17.90%
Profitability
ROCE
17.30%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical business
+9.8%100.0%
₹4,051.12 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.4%
International
99.6%
North America53.8%
Europe22.2%
Africa11.9%
Australia11.0%
Others0.4%
India0.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
P
Pharmagel s r 1
Italy
0.00% stakeA
Arcolab S A
Switzerland
0.00% stakeM
M/s Kathabar Systems
Holland
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.57x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
7.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.